Effect of two different dietary fatty acid profiles and variant rs266729 in ADIPOQ on weight loss and adiponectin concentrations

The role of ADIPOQ gene rs266729 variants on weight loss after a dietary intervention are still unclear. To analyze the effects of the ADIPOQ gene rs266729 variant n weight loss, cardiovascular risk factors, and adiponectin levels after two hypocaloric diets with different dietary fatty profiles. A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinología, diabetes y nutrición diabetes y nutrición, 2020-06, Vol.67 (6), p.374-382
Hauptverfasser: de Luis, D.A., Primo, D., Izaola, O., Aller, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The role of ADIPOQ gene rs266729 variants on weight loss after a dietary intervention are still unclear. To analyze the effects of the ADIPOQ gene rs266729 variant n weight loss, cardiovascular risk factors, and adiponectin levels after two hypocaloric diets with different dietary fatty profiles. A population of 362 obese patients was enrolled in a randomized clinical trial with two diets (Diet M, monounsaturated fat-enriched diet, and Diet P, polyunsaturated-fat enriched diet). Anthropometric measurements, an assessment of nutritional intake, and biochemical tests were performed at baseline and after 12 weeks. Weight loss was similar with both diets. After Diet M, only subjects with CC genotype showed significant improvements in total cholesterol (CC vs. CG±GG) (−9.0±1.1mU/L vs. −4.5±2.4mg/dL, p=0.01), LDL cholesterol (−6.0±1.1mg/dL vs. −3.0±0.9mg/dL, p=0.03), glucose (−4.7±1.1mg/dL vs. −0.6±0.5mg/dL, p=0.01), and insulin levels (−2.6±1.0mU/L vs. −0.7±0.3mU/L, p=0.02) and in HOMA-IR (−0.5±0.2 units vs. −0.2±0.4 units, p=0.03). The same improvement was reported after Diet P in all parameters, including total cholesterol (CC vs. CG±GG) (−8.0±1.2mU/L vs. −2.1±1.4mg/dL, p=0.02), LDL cholesterol (−7.3±1.2mg/dL vs. −2.1±0.8mg/dL, p=0.02), glucose (−3.2±0.1mg/dL vs. −0.2±0.5mg/dL, p=0.01), and insulin levels (−2.5±1.0mU/L vs. −1±0.6mU/L, p=0.02) and HOMA-IR (−0.5±0.1 units vs. −0.3±0.4 units, p=0.02). Only subjects with CC genotype showed significant increases in adiponectin levels after both diets: (Diet M: 10.3±2.0ng/dL vs. Diet P: 9.3±2.9ng/dL, p=0.43). The CC genotype of ADIPOQ gene rs266729 variant is associated to increased adiponectin levels and decreases in LDL cholesterol, glucose, insulin, and HOMA-IR levels after weight loss. El papel de las variantes del gen ADIPOQ en la pérdida de peso después de una intervención dietética sigue sin estar claro. Nuestro objetivo fue analizar los efectos de la variante rs266729 del gen ADIPOQ sobre la pérdida de peso, los factores de riesgo cardiovascular y los niveles de adiponectina después de 2 dietas hipocalóricas con diferentes perfiles de grasas en la dieta. Una población de 362 pacientes obesos se incluyeron en un ensayo clínico aleatorizado con 2 dietas (dieta M: dieta enriquecida con grasas monoinsaturadas y dieta P: dieta enriquecida con grasas poliinsaturadas). Antes y tras 12 semanas, se realizó una evaluación antropométrica, evaluación de la ingesta nutricional y un análisis bioquímico. La pérdida de pes
ISSN:2530-0164
2530-0180
DOI:10.1016/j.endinu.2019.09.004